Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALDF
1701
Aldel Financial II Inc
ALDF
$322M
| $210K | ﹤0.01% |
20,000
-10,000
| -33% | -$105K |
|
1702
Credicorp
BAP
$30.2B
| $209K | ﹤0.01% |
+728
| New | +$193K |
|
1703
Box
BOX
$4.64B
| $209K | ﹤0.01% |
6,977
-80,045
| -92% | -$2.51M |
|
1704
Harmonic Inc
HLIT
$1.31B
| $207K | ﹤0.01% |
+20,941
| New | +$211K |
|
1705
Peapack-Gladstone Financial
PGC
$804M
| $206K | ﹤0.01% |
+7,384
| New | +$201K |
|
1706
Stock Yards Bancorp
SYBT
$2.54B
| $205K | ﹤0.01% |
3,160
-3,292
| -51% | -$221K |
|
|
SBXD
1707
SilverBox Corp IV
SBXD
$285M
| $205K | ﹤0.01% |
+19,355
| New | +$204K |
|
|
ASIC
1708
Ategrity Specialty Insurance
ASIC
$1.26B
| $204K | ﹤0.01% |
9,722
-53,336
| -85% | -$1.01M |
|
1709
American Eagle Outfitters
AEO
$2.83B
| $203K | ﹤0.01% |
7,698
-169,143
| -96% | -$3.34M |
|
1710
Stepan Co
SCL
$1.41B
| $203K | ﹤0.01% |
4,280
-3,812
| -47% | -$175K |
|
1711
Equitable Holdings
EQH
$13.4B
| $203K | ﹤0.01% |
4,250
-118,550
| -97% | -$5.62M |
|
|
APXTU
1712
Apex Treasury Corp Units
APXTU
| $202K | ﹤0.01% |
+19,869
| New | +$200K |
|
1713
Helmerich & Payne
HP
$4.25B
| $201K | ﹤0.01% |
7,017
-33,451
| -83% | -$889K |
|
1714
Diamondrock Hospitality Co
DRH
$2.61B
| $201K | ﹤0.01% |
22,439
-191
| -0.8% | -$1.63K |
|
1715
Atlanta Braves Holdings Series A
BATRA
$3.68B
| $201K | ﹤0.01% |
+4,720
| New | +$203K |
|
1716
Orrstown Financial Services
ORRF
$828M
| $200K | ﹤0.01% |
+5,660
| New | +$198K |
|
1717
Enovix
ENVX
$718M
| $200K | ﹤0.01% |
+27,318
| New | +$265K |
|
|
LOVE
1718
LoveSac
LOVE
$232M
| $198K | ﹤0.01% |
+13,448
| New | +$190K |
|
1719
Pitney Bowes
PBI
$2.27B
| $197K | ﹤0.01% |
+18,641
| New | +$193K |
|
1720
Sigma Lithium
SGML
$1.37B
| $197K | ﹤0.01% |
+14,900
| New | +$128K |
|
|
GPAT
1721
GP-Act III Acquisition Corp
GPAT
$177M
| $193K | ﹤0.01% |
18,053
-1,138
| -6% | -$12.1K |
|
|
NOA
1722
North American Construction
NOA
$361M
| $190K | ﹤0.01% |
+13,247
| New | +$189K |
|
1723
Fulcrum Therapeutics
FULC
$293M
| $190K | ﹤0.01% |
16,791
-349,512
| -95% | -$3.56M |
|
1724
Fate Therapeutics
FATE
$292M
| $189K | ﹤0.01% |
192,682
-351,905
| -65% | -$423K |
|
1725
Sharplink Inc
SBET
$1.79B
| $189K | ﹤0.01% |
+21,163
| New | +$258K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.